-
Home
- Investor Relations
- News
-
Back
-
The annual turnover of the Company in 2015 reached up to RMB 3.71 billion, up 40.0% year-on-year, exploring the market of TCM formula granules and becoming a leading enterprise in the traditional Chinese medicine industry
[2016-03-21]
-
Net profit attributable to shareholders of the Group for the first half of 2015 reached RMB 235 million, with a year-on-year growth of 24.3%, being committed to improving the layout of the industrial chain and expanding TCM health services
[2015-08-20]
-
The turnover of China TCM reached as high as RMB 2.69 billion, up 92.9% year-on-year, marching into the market of TCM formula granules and striving to become a leading enterprise in the traditional Chinese medicine industry
[2015-03-16]
-
China TCM acquired 81.48% of the registered capital of Jiangyin Tianjiang Pharmaceutical Co., Ltd., entering the rapidly-growing market of TCM formula granules
[2015-01-27]
-
The net profit of China TCM hit a record high, up 200% year-on-year to RMB189 million, grasping the opportunity of industrial reform and consolidating its leading position in China TCM industry
[2014-08-31]